Isolated blast crisis in CNS in a patient with chronic myelogenous leukemia maintaining major cytogenetic response after imatinib

被引：22

作者：

Kim, Hyun Jung ^{[1
]}

Jung, Chul Won

Kim, Kihyun

Ahn, Jin Seok

Kim, Won Seog

Park, Kwan

Ko, Young Hye

Kang, Won Ki

Park, Keunchil

机构：

[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea

[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea

[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 24期

关键词：

D O I：

10.1200/JCO.2006.05.5608

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：4028 / 4029

页数：2

共 10 条

[1] CNS blast crisis of chronic myelogenous leukemia in a patient with a major cytogenetic response in bone marrow associated with low levels of imatinib mesylate and its N-desmethylated metabolite in cerebral spinal fluid [J].

Bornhauser, M ;

Jenke, A ;

Freiberg-Richter, J ;

Radke, J ;

Schuler, US ;

Mohr, B ;

Ehninger, G ;

Schleyer, E .

ANNALS OF HEMATOLOGY, 2004, 83 (06) :401-402

[2] Isolated central nervous system relapse in lymphoid blast crisis chronic myeloid leukemia and acute lymphoblastic leukemia in patients on imatinib therapy [J].

Bujassoum, S ;

Rifkind, J ;

Lipton, JH .

LEUKEMIA & LYMPHOMA, 2004, 45 (02) :401-403

[3] Distribution of STI-571 to the brain is limited by P-glycoprotein-mediated efflux [J].

Dai, HQ ;

Marbach, P ;

Lemaire, M ;

Hayes, M ;

Elmquist, WF .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (03) :1085-1092

[4] Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia [J].

Hughes, TP ;

Kaeda, J ;

Branford, S ;

Rudzki, Z ;

Hochhaus, A ;

Hensley, ML ;

Gathmann, I ;

Bolton, AE ;

van Hoomissen, IC ;

Goldman, JM ;

Radich, JP ;

Taylor, K ;

Durrant, S ;

Schwarer, A ;

Joske, D ;

Seymour, J ;

Grigg, A ;

Ma, D ;

Arthur, C ;

Bradstock, K ;

Joshua, D ;

Lechner, K ;

Verhoef, G ;

Louwagie, A ;

Martiat, P ;

Straetmans, N ;

Bosly, A ;

Shepherd, J ;

Shustik, C ;

Lipton, J ;

Kovacs, DM ;

Turner, AR ;

Nielsen, JL ;

Birgens, H ;

Bjerrum, OW ;

Guilhot, F ;

Reiffers, J ;

Rousselot, P ;

Facon, T ;

Harousseau, JL ;

Tulliez, M ;

Guerci, A ;

Blaise, D ;

Maloisel, F ;

Michallet, M ;

Fischer, T ;

Hossfeld, D ;

Mertelsmann, R ;

Andreesen, R ;

Nerl, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (15) :1423-1432

[5] Central nervous system failure in patients with chronic myelogenous leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with Imatinib (STI-571) [J].

Leis, JF ;

Stepan, DE ;

Curtin, PT ;

Ford, JM ;

Peng, B ;

Schubach, S ;

Druker, BJ ;

Maziarz, RT .

LEUKEMIA & LYMPHOMA, 2004, 45 (04) :695-698

[6] Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia [J].

O'Brien, SG ;

Guilhot, F ;

Larson, RA ;

Gathmann, I ;

Baccarani, M ;

Cervantes, F ;

Cornelissen, JJ ;

Fischer, T ;

Hochhaus, A ;

Hughes, T ;

Lechner, K ;

Nielsen, JL ;

Rousselot, P ;

Reiffers, J ;

Saglio, G ;

Shepherd, J ;

Simonsson, B ;

Gratwohl, A ;

Goldman, JM ;

Kantarjian, H ;

Taylor, K ;

Verhoef, G ;

Bolton, AE ;

Capdeville, R ;

Druker, BJ ;

Durrant, S ;

Schwarer, A ;

Joske, D ;

Seymour, J ;

Grigg, A ;

Ma, D ;

Arthur, C ;

Bradstock, K ;

Joshua, D ;

Louwagie, A ;

Martiat, P ;

Straetmans, N ;

Bosly, A ;

Shustik, C ;

Lipton, J ;

Forrest, D ;

Walker, I ;

Roy, DC ;

Rubinger, M ;

Bence-Bruckler, I ;

Kovacs, M ;

Turner, AR ;

Birgens, H ;

Bjerrum, O ;

Facon, T .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (11) :994-1004

[7] Imatinib mesylate - The new gold standard for treatment of chronic myeloid leukemia [J].

Peggs, K ;

Mackinnon, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (11) :1048-1050

[8] Low concentrations of STI571 in the cerebrospinal fluid:: a case report [J].

Petzer, AL ;

Gunsilius, E ;

Hayes, M ;

Stockhammer, G ;

Duba, HC ;

Schneller, F ;

Grünewald, K ;

Poewe, W ;

Gastl, G .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (03) :623-625

[9] Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid [J].

Takayama, N ;

Sato, N ;

O'Brien, SG ;

Ikeda, Y ;

Okamoto, SI .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (01) :106-108

[10] The CNS is a sanctuary for leukemic cells in mice receiving imatinib mesylate for Bcr/Abl-induced leukemia [J].

Wolff, NC ;

Richardson, JA ;

Egorin, M ;

Ilaria, RL .

BLOOD, 2003, 101 (12) :5010-5013

← 1 →